Frontlight ResearchEarly access
Liver cirrhosis trials in Poland
6 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Where
- Częstochowa, Gdansk, Katowice, Krakow, Lodz, Poznan, Warsaw, Wroclaw
- Age
- 18 years to 80 years
- People
- 2,150 worldwide
- Run by
- Akero Therapeutics, Inc
See details and how to joinNCT06528314 - Phase 3Taking peopleLIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- Where
- Cracow, Lodz, Lublin, Myslowice, Warsaw, Wroclaw
- Age
- 18 years and over
- People
- 1,590 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632457 · EU 2024-513741-36-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- Where
- Cracow, Lodz, Myslowice, Warsaw, Wroclaw
- Age
- 18 years to 75 years
- People
- 1,800 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06419374 · EU 2023-510395-31-00 - No phaseTaking peopleLiver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
- Where
- Warsaw
- Age
- 18 years to 80 years
- People
- 3,000 worldwide
- Run by
- European Foundation for Study of Chronic Liver Failure
See details and how to joinNCT04613921 - No phaseTaking peoplePortal Inflow Modulation Prior to Liver Transplantation in Patients With Increased Risk of Intraoperative Blood Loss
- Where
- Warsaw
- Age
- 18 years and over
- People
- 104
- Run by
- Medical University of Warsaw
See details and how to joinNCT07111221 - Phase 3Not yet taking people in PolandNamodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
- Where
- Koszalin, Krakow, Mysłowice, Przemyśl, Warsaw, Wroclaw
- Age
- 18 years and over
- People
- 471 worldwide
- Run by
- Can-Fite BioPharma
See details and how to joinNCT05201404